» Articles » PMID: 32240949

Exercise-Mediated Lowering of Glutamine Availability Suppresses Tumor Growth and Attenuates Muscle Wasting

Overview
Journal iScience
Publisher Cell Press
Date 2020 Apr 3
PMID 32240949
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Glutamine is a central nutrient for many cancers, contributing to the generation of building blocks and energy-promoting signaling necessary for neoplastic proliferation. In this study, we hypothesized that lowering systemic glutamine levels by exercise may starve tumors, thereby contributing to the inhibitory effect of exercise on tumor growth. We demonstrate that limiting glutamine availability, either pharmacologically or physiologically by voluntary wheel running, significantly attenuated the growth of two syngeneic murine tumor models of breast cancer and lung cancer, respectively, and decreased markers of atrophic signaling in muscles from tumor-bearing mice. In continuation, wheel running completely abolished tumor-induced loss of weight and lean body mass, independently of the effect of wheel running on tumor growth. Moreover, wheel running abolished tumor-induced upregulation of muscular glutamine transporters and myostatin signaling. In conclusion, our data suggest that voluntary wheel running preserves muscle mass by counteracting muscular glutamine release and tumor-induced atrophic signaling.

Citing Articles

Untargeted Metabolomics and Proteomics-Based Research of the Long-Term Exercise on Human Body.

Zhuang W, Wang Y, Xu X, Zhao J Appl Biochem Biotechnol. 2025; .

PMID: 39937413 DOI: 10.1007/s12010-025-05195-3.


Weight Management for Fertility-Preservation Therapy in Endometrial Cancer: Opportunities and Challenges.

Li X, Chen Y, Li X, Yang X, Zhou L, Cheng Y Curr Oncol Rep. 2025; .

PMID: 39913071 DOI: 10.1007/s11912-025-01635-9.


Exploring the role of adipokines in exercise-induced inhibition of tumor growth.

Qian Y, Bu Z, Qin Y, Qian S, Qin L, Zhou S Sports Med Health Sci. 2025; 7(2):143-156.

PMID: 39811408 PMC: 11726049. DOI: 10.1016/j.smhs.2024.03.006.


Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma.

Duraj T, Kalamian M, Zuccoli G, Maroon J, DAgostino D, Scheck A BMC Med. 2024; 22(1):578.

PMID: 39639257 PMC: 11622503. DOI: 10.1186/s12916-024-03775-4.


Combined proteomics and metabolomics analysis reveal the effect of a training course on the immune function of Chinese elite short-track speed skaters.

Li T, Shao J, An N, Chang Y, Xia Y, Han Q Immun Inflamm Dis. 2024; 12(10):e70030.

PMID: 39352112 PMC: 11443606. DOI: 10.1002/iid3.70030.


References
1.
Hafliger P, Graff J, Rubin M, Stooss A, Dettmer M, Altmann K . The LAT1 inhibitor JPH203 reduces growth of thyroid carcinoma in a fully immunocompetent mouse model. J Exp Clin Cancer Res. 2018; 37(1):234. PMC: 6150977. DOI: 10.1186/s13046-018-0907-z. View

2.
Gaglio D, Metallo C, Gameiro P, Hiller K, Danna L, Balestrieri C . Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth. Mol Syst Biol. 2011; 7:523. PMC: 3202795. DOI: 10.1038/msb.2011.56. View

3.
Kuhn K, Schuhmann K, Stehle P, Darmaun D, Furst P . Determination of glutamine in muscle protein facilitates accurate assessment of proteolysis and de novo synthesis-derived endogenous glutamine production. Am J Clin Nutr. 1999; 70(4):484-9. DOI: 10.1093/ajcn/70.4.484. View

4.
Lofberg E, Gutierrez A, Wernerman J, Anderstam B, Mitch W, Price S . Effects of high doses of glucocorticoids on free amino acids, ribosomes and protein turnover in human muscle. Eur J Clin Invest. 2002; 32(5):345-53. DOI: 10.1046/j.1365-2362.2002.00993.x. View

5.
Plumley D, Souba W, Hautamaki R, MARTIN T, Flynn T, ROUT W . Accelerated lung amino acid release in hyperdynamic septic surgical patients. Arch Surg. 1990; 125(1):57-61. DOI: 10.1001/archsurg.1990.01410130063008. View